Improvement of Anaemia in Patients with Primary Myelofibrosis by Low-Dose Thalidomide and Prednisone
Background: A combination of low-dose thalidomide and corticosteroids is a treatment option for anaemic patients with primary myelofibrosis (PMF) who are not eligible for allogeneic hematopoietic stem cell transplantation. Methods: We describe the outcomes of 13 patients with PMF treated with thalid...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karolinum Press
2016-08-01
|
Series: | Acta Medica |
Subjects: | |
Online Access: | http://actamedica.lfhk.cuni.cz/59/2/0050/ |